ArticleScientific reports2026
A robust stacked ensemble strategy with multi-optimizer CNN models for skin cancer classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is one of the most prevalent and potentially life-threatening cancers globally, making it a critical area of focus in medical research. Early detection, followed by timely and appropriate treatment, can significantly enhance patient survival outcomes. In recent years, computer-aided diagnostic systems have gained substantial attention for their ability to support accurate and efficient skin cancer diagnosis. This study presents an optimized stacked ensemble strategy to improve skin lesion classification performance. Experiments were conducted on the Melanoma Skin Cancer Dataset using four different convolutional neural network (CNN) architectures, each trained with different optimizers, including Adam, Stochastic Gradient Descent (SGD), Root Mean Square Propagation (RMSprop), and AdaMax (Adamax). All models were trained using categorical cross-entropy loss and evaluated based on validation accuracy, with hyperparameters such as learning rate, batch size, and number of epochs kept constant. More than 90 model combinations were tested using four ensemble strategies: soft and hard voting, weighted voting (using grid search), and stacked ensemble using various meta-learners (Gradient Boosting (GB), k-Nearest Neighbors (KNN), Support Vector Machine (SVM), Logistic Regression (LR), and Naïve Bayes (NB)). The models and ensembles were assessed using standard performance metrics including accuracy, precision, recall, F1-score, and Area Under the Receiver Operating Characteristic Curve (ROC-AUC). Among the evaluated configurations, the stacked ensemble model with Gradient Boosting (GB) as the meta-classifier and M1+M2+M3+M4 as the deep learning base models achieved a validation accuracy of 97.4% and a robust independent test accuracy of 91.80% with a ROC-AUC of 96.87%. The findings demonstrate that ensemble learning, particularly stacked ensembling, significantly enhances classification accuracy and strengthens the reliability of melanoma detection on unseen datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.